Research article · 27 Jul 2026
Mini reviewPublished 28 Jul 2022
Biopharmaceutical Manufacturing: An Evolving Industry
Department of Pharmaceutics and Medicinal Chemistry, University of the Pacific, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The biopharmaceutical assiduity is evolving with a shift in focus from recombinant proteins and antibodies towards more complex cell and gene curatives. To be competitive encyclopaedically, bio manufacturers need to concentrate on aligning with global norms with regard to medicine quality, reducing manufacturing failures and delivering medicines to vend snappily. Erecting these capabilities requires a multifaceted approach that includes advancements in operations, quality compliance, and control strategies. To address these requirements, the US Pharmacopeia (USP), the Department of Biotechnology (DBT) India, and the Confederation of Indian Industry (CII) held a council to bandy the conditions and gaps in the biotechnology and pharmaceutical sectors in India and other developing countries.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “James A Uchizono”
